ENPP1 and viral infectious disease: ENPP1 inhibitors, and perhaps even cGAMP-specific ENPP1 inhibitors, may be therapeutically beneficial during viral infection, while administering recombinant ENPP1 or blocking cGAMP import may reduce extracellular cGAMP-associated inflammation.